These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 7542253

  • 1. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.
    Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF.
    J Cell Biochem; 1995 Apr; 57(4):680-90. PubMed ID: 7542253
    [Abstract] [Full Text] [Related]

  • 2. Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion.
    Xuan JW, Hota C, Chambers AF.
    J Cell Biochem; 1994 Feb; 54(2):247-55. PubMed ID: 8175899
    [Abstract] [Full Text] [Related]

  • 3. Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.
    Chambers AF, Hota C, Prince CW.
    Cancer Res; 1993 Feb 01; 53(3):701-6. PubMed ID: 8425206
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin.
    Bautista DS, Xuan JW, Hota C, Chambers AF, Harris JF.
    J Biol Chem; 1994 Sep 16; 269(37):23280-5. PubMed ID: 8083234
    [Abstract] [Full Text] [Related]

  • 5. Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells.
    Nasu K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S.
    Biochem J; 1995 Apr 01; 307 ( Pt 1)(Pt 1):257-65. PubMed ID: 7717985
    [Abstract] [Full Text] [Related]

  • 6. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF, Behrend EI, Wilson SM, Denhardt DT.
    Anticancer Res; 1992 Apr 01; 12(1):43-7. PubMed ID: 1567180
    [Abstract] [Full Text] [Related]

  • 7. The carboxyl-terminal fragment of osteopontin suppresses arginine-glycine-asparatic acid-dependent cell adhesion.
    Takahashi K, Takahashi F, Tanabe KK, Takahashi H, Fukuchi Y.
    Biochem Mol Biol Int; 1998 Dec 01; 46(6):1081-92. PubMed ID: 9891840
    [Abstract] [Full Text] [Related]

  • 8. Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment.
    van Dijk S, D'Errico JA, Somerman MJ, Farach-Carson MC, Butler WT.
    J Bone Miner Res; 1993 Dec 01; 8(12):1499-506. PubMed ID: 8304052
    [Abstract] [Full Text] [Related]

  • 9. Non-RGD domains of osteopontin promote cell adhesion without involving alpha v integrins.
    Katagiri YU, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia WY, Chambers AF, Uede T.
    J Cell Biochem; 1996 Jul 01; 62(1):123-31. PubMed ID: 8836881
    [Abstract] [Full Text] [Related]

  • 10. Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.
    Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L.
    Mol Biol Cell; 1994 May 01; 5(5):565-74. PubMed ID: 7522656
    [Abstract] [Full Text] [Related]

  • 11. Promotion of selective cell attachment by the RGD sequence in dentine matrix protein 1.
    Kulkarni GV, Chen B, Malone JP, Narayanan AS, George A.
    Arch Oral Biol; 2000 Jun 01; 45(6):475-84. PubMed ID: 10775676
    [Abstract] [Full Text] [Related]

  • 12. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
    Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA.
    Lab Invest; 1999 Jul 01; 79(7):869-77. PubMed ID: 10418827
    [Abstract] [Full Text] [Related]

  • 13. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5.
    Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW.
    J Biol Chem; 1995 Nov 03; 270(44):26232-8. PubMed ID: 7592829
    [Abstract] [Full Text] [Related]

  • 14. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
    Allan AL, George R, Vantyghem SA, Lee MW, Hodgson NC, Engel CJ, Holliday RL, Girvan DP, Scott LA, Postenka CO, Al-Katib W, Stitt LW, Uede T, Chambers AF, Tuck AB.
    Am J Pathol; 2006 Jul 03; 169(1):233-46. PubMed ID: 16816376
    [Abstract] [Full Text] [Related]

  • 15. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.
    Senger DR, Perruzzi CA.
    Biochim Biophys Acta; 1996 Nov 08; 1314(1-2):13-24. PubMed ID: 8972713
    [Abstract] [Full Text] [Related]

  • 16. Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro.
    Grzesik WJ, Robey PG.
    J Bone Miner Res; 1994 Apr 08; 9(4):487-96. PubMed ID: 7518179
    [Abstract] [Full Text] [Related]

  • 17. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts.
    Gardner HA, Berse B, Senger DR.
    Oncogene; 1994 Aug 08; 9(8):2321-6. PubMed ID: 8036014
    [Abstract] [Full Text] [Related]

  • 18. Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin.
    Smith LL, Giachelli CM.
    Exp Cell Res; 1998 Jul 10; 242(1):351-60. PubMed ID: 9665832
    [Abstract] [Full Text] [Related]

  • 19. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL, Chambers AF.
    J Cell Biochem; 2000 Apr 10; 78(1):8-23. PubMed ID: 10797562
    [Abstract] [Full Text] [Related]

  • 20. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments.
    Gao YA, Agnihotri R, Vary CP, Liaw L.
    Matrix Biol; 2004 Nov 10; 23(7):457-66. PubMed ID: 15579312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.